Sanofi Quarterly Results for Trading Insights
In Mar 2025, Sanofi (SANOFI) reported revenue ₹539 Cr and net profit ₹120 Cr — revenue -6.9% YoY. Also explore Sanofi share price performance to track price trends across different timeframes.
SANOFI Quarterly Results — Revenue, Profit & EPS Highlights
Sanofi latest quarter revenue, net profit, EPS and QoQ/YoY growth rates. For annual financials, live price and key ratios, visit SANOFI share price screener.
- Revenue of ₹539 Cr in Mar 2025 (+2.5% vs Sept 2024, -6.9% vs Mar 2024)
- Net Profit of ₹120 Cr in Mar 2025 (+46.3% vs Sept 2024, -12.4% vs Mar 2024)
- EBITDA of ₹175 Cr in Mar 2025 (+43.4% vs Sept 2024)
- Operating Margin of 32.0% in Mar 2025 (+9.0pp vs Sept 2024)
- Earnings Per Share of ₹51.89 in Mar 2025 (+45.4% vs Sept 2024)
Sanofi Quarterly Results — Revenue, EBITDA, Net Profit & EPS
SANOFI quarterly revenue, expenses, EBITDA, net profit, EPS and operating margin with QoQ and YoY comparison.
| Metric | Mar 2025 | Sept 2024 | Mar 2024 | Jun 2024 | Dec 2024 | QoQ | YoY |
|---|---|---|---|---|---|---|---|
| Revenue (₹ Cr) | 539 | 526 | 579 | 503 | 529 | 2.5% | -6.9% |
| Net Profit (₹ Cr) | 120 | 82 | 137 | 103 | 91 | - | - |
| EBITDA (₹ Cr) | 175 | 122 | 179 | 137 | 132 | - | - |
| EPS (₹) | 51.89 | 35.69 | 59.31 | 44.81 | 39.64 | - | - |
| Operating Margin (%) | 32.0% | 23.0% | 22.0% | 21.0% | 23.0% | - | - |
SANOFI Share Price Trend — 1-Year Movement Across Quarterly Results
Sanofi 1-year share price in ₹ overlaid with quarterly earnings dates — NSE/BSE closing prices. Compare with Sanofi value estimation to assess whether the stock is under or overvalued.
Revenue Trend (₹ Cr)
Net Profit Trend (₹ Cr)
Operating Margin Trend (%)
SANOFI vs Healthcare Peers — Quarterly Revenue, Profit & Market Cap
Sanofi latest quarter revenue and net profit vs Healthcare competitors — market cap, price and earnings comparison.
| Company Latest Quarter | Market Cap (₹ Cr) | Price (₹) | Revenue (₹ Cr) | Net Profit (₹ Cr) | Rev QoQ % | Rev YoY % | Profit Margin % | P/E Ratio |
|---|---|---|---|---|---|---|---|---|
|
Sun Pharmaceutical
Mar 2026 |
₹442,581.33 Cr | 1844.3 | 15,018 | 2,710 | +1.0% | +11.8% | 18.0% | 163.2 |
|
Divis Laboratories
Mar 2026 |
₹179,363.85 Cr | 6797.5 | 2,986 | 751 | +4.4% | +11.8% | 25.2% | 240.1 |
|
Torrent Pharmaceuti…
Mar 2026 |
₹153,579.77 Cr | 4537.8 | 4,111 | 364 | +27.7% | +42.2% | 8.9% | 394.2 |
|
Cipla
Mar 2026 |
₹114,559.46 Cr | 1418.2 | 6,612 | 543 | -14.3% | -4.0% | 8.2% | 206.4 |
|
Dr Reddys Laborator…
Mar 2026 |
₹110,089.41 Cr | 1319.0 | 7,996 | 221 | -12.5% | -11.5% | 2.8% | 497.7 |
All amounts in ₹ Crores